On 26 August 2014
Strides Arcolab announced that the Company has received US FDA approval for Buspirone Hydrochloride Tablets USP, 5 mg, 10 mg, 15 mg and 30 mg. The product will be manufactured at the Company's oral dosage facility in Bangalore and marketed directly by Strides in the US market.The Buspirone Tablets are used for the treatment of anxiety disorders and the short term relief of the symptoms of anxiety.
Powered by Capital Market - Live News
